Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options

Fig. 2

Mutational profiling of YST-R. A Tumor mutational burden score (TMB) and microsatellite instability score (MSI) found in six cisplatin-resistant YST samples. B Pearson’s correlation plot of TMB and MSI. C List of identified individual and common genomic alterations found in six cisplatin-resistant YST tissues

Back to article page